Durvalumab,Tremelimumab
AstraZeneca,Pfizer
[]
understanding resistance to icis important in msi-h cancers concept of immune priming-even if pd on io ?possible to salvage with chemo /other strategies great case from infinity neoadjuvant stride in gej/gc fabulous talk #wcgic2023 
Medical Oncologist; clinical and translational researcher pancreatic and hepatobiliary cancers. Views are my own 🇮🇪🇨🇦